Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,658 | 55,022 | 30,665 | 11,249 | 10,024 |
| TOTAL | $62,018 | $57,627 | $33,396 | $13,948 | $11,553 |
| Non-Current Assets | |||||
| PPE Net | 4,044 | 37 | 28 | 34 | 34 |
| Intangibles | 120 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 1,435 | 561 | 388 | 456 | 565 |
| TOTAL | $5,599 | $718 | $536 | $610 | $719 |
| Total Assets | $67,617 | $58,345 | $33,932 | $14,558 | $12,272 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,770 | 3,189 | 1,408 | 3,070 | 1,119 |
| Accrued Expenses | 2,073 | 1,143 | 996 | 1,713 | 832 |
| TOTAL | $4,378 | $4,678 | $2,660 | $5,135 | $2,366 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 671 | 95 | 25 | 6 | 51 |
| TOTAL | $671 | $95 | $25 | $6 | $51 |
| Total Liabilities | $5,049 | $4,773 | $2,685 | $5,141 | $2,417 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 156,585 | 130,274 | 52,302 | 49,353 | 1,575 |
| Common Shares | 140 | 105 | 49 | 9 | 2 |
| Retained earnings | -250,512 | -238,522 | -224,343 | -217,070 | -208,363 |
| Other shareholders' equity | -64 | -69 | -60 | -46 | -42 |
| TOTAL | $62,568 | $53,572 | $31,247 | $9,417 | $9,855 |
| Total Liabilities And Equity | $67,617 | $58,345 | $33,932 | $14,558 | $12,272 |